Lihong Nan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lihong Nan has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Yaping Chen
College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China
5 shared publications- Yuqin Zhang
College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, China
5 shared publications Mei Huang
College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, China
4 shared publicationsWen Xu
College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, China
4 shared publicationsXuezhen Li
Institute of Structural Pharmacology & TCM Chemical Biology, Fujian Key Laboratory of Chinese Materia Medica, College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, China
3 shared publications- Hua Li
Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China; Institute of Structural Pharmacology & TCM Chemical Biology, College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, China
2 shared publications
Latest Publications
- Open Access
- 9 March 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Physcion-8-O-β-D-monoglucoside protects hepatocytes from TNF-α-mediated apoptosis by suppressing the PI3K/AKT/NF-κB signaling pathway
Physcion-8-O-β-D-monoglucoside (PMG) is one of the active ingredients of Radix et Rhizoma Rhei, which has been used for treating liver diseases for hundreds of years in China. However, the hepatoprotective effects of PMG remain poorly understood. This study aimed to investigate the mechanism of the protection effects of PMG on tumor necrosis factor-α (TNF-α)-induced hepatotoxicity. We developed both in vitro and in vivo models of liver injury to assess the protective effects of PMG against TNF-α-induced hepatotoxicity. The in vitro model employed TNF-α/actinomycin D in AML-12 cells, while the in vivo model utilized intraperitoneal injection of carbon tetrachloride (CCl4) in mice. Interactions of PMG and TNFR1 (the receptor of TNF-α) were explored by molecular docking. AAV resuspension was administered before PMG treatment via intravenous injection to overexpress TNF-α in the CCl4-induced mice. The effects of PMG on liver injury were assessed using CCK-8 assay, AST/ALT level measurement, and HE staining. Cell apoptosis was detected through Hoechst staining, TUNEL staining, and the levels of cleaved caspase-3. mRNA expression of TNF-α and IL-6 was quantified using real-time PCR, while the related proteins were detected by Western blotting. The protein localization of TNF-α was visualized by immunofluorescence assays. PMG effectively protected against hepatotoxicity in vitro and in vivo by restoring cell survival, decreasing AST, ALT, and reducing apoptosis. TNF-α overexpression counteracted the hepatoprotective effects of PMG, thereby attenuating its regulatory impacts on apoptosis and the dysregulation of the PI3K/AKT/NF-κB signaling pathway. Notably, PMG ameliorated hepatotoxicity by restoring the TNF-α-mediated apoptosis signaling pathway, supporting its potential as a novel therapeutic for acute liver injury.
- 9 March 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessPhyscion-8-O-β-D-monoglucoside protects hepatocytes from TNF-α-mediated apoptosis by suppressing the PI3K/AKT/NF-κB signaling pathway
Physcion-8-O-β-D-monoglucoside (PMG) is one of the active ingredients of Radix et Rhizoma Rhei, which has been used for treating liver diseases for hundreds of years in China. However, the hepatoprotective effects of PMG remain poorly understood. This study aimed to investigate the mechanism of the protection effects of PMG on tumor necrosis factor-α (TNF-α)-induced hepatotoxicity. We developed both in vitro and in vivo models of liver injury to assess the protective effects of PMG against TNF-α-induced hepatotoxicity. The in vitro model employed TNF-α/actinomycin D in AML-12 cells, while the in vivo model utilized intraperitoneal injection of carbon tetrachloride (CCl4) in mice. Interactions of PMG and TNFR1 (the receptor of TNF-α) were explored by molecular docking. AAV resuspension was administered before PMG treatment via intravenous injection to overexpress TNF-α in the CCl4-induced mice. The effects of PMG on liver injury were assessed using CCK-8 assay, AST/ALT level measurement, and HE staining. Cell apoptosis was detected through Hoechst staining, TUNEL staining, and the levels of cleaved caspase-3. mRNA expression of TNF-α and IL-6 was quantified using real-time PCR, while the related proteins were detected by Western blotting. The protein localization of TNF-α was visualized by immunofluorescence assays. PMG effectively protected against hepatotoxicity in vitro and in vivo by restoring cell survival, decreasing AST, ALT, and reducing apoptosis. TNF-α overexpression counteracted the hepatoprotective effects of PMG, thereby attenuating its regulatory impacts on apoptosis and the dysregulation of the PI3K/AKT/NF-κB signaling pathway. Notably, PMG ameliorated hepatotoxicity by restoring the TNF-α-mediated apoptosis signaling pathway, supporting its potential as a novel therapeutic for acute liver injury.
- Open Access
- 4 September 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1649327
Isorhamnetin attenuates renal interstitial fibrosis by targeting TWEAK/Fn14-mediated epithelial–mesenchymal transition
Introduction: Isorhamnetin (ISO), a prominent active compound found in the fruits of Hippophae rhamnoides L., exhibits various pharmacological activities. Recent studies have demonstrated that ISO possesses a significant renoprotective effect. Nevertheless, the specific targets and mechanisms through which ISO exerts its effects against renal interstitial fibrosis (RIF) remain insufficiently explored. The aims of this study were to explore the protective effects of ISO regulating epithelial–mesenchymal transition (EMT) and relieving RIF and to elucidate the underlying molecular mechanisms involved in the tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor-inducible molecule 14 (Fn14) pathway.Methods: We explored the potential effects and mechanisms of ISO on RIF by using an in vitro EMT model of a transforming growth factor-β (TGF-β)-induced human proximal tubular cell line (HK-2) and an in vivo unilateral ureteral obstruction (UUO) model. The potential mechanism of the TWEAK/Fn14 pathway involving the protective action of ISO on renal tubules was explored by surface plasmon resonance (SPR) analysis and Fn14 overexpression on UUO rats.Results: Our findings reveal that ISO can enhance cell morphology and effectively inhibit the migration ability of TGF-β-induced HK-2 cells. ISO also improved renal dysfunction and reduced tubular damage induced by UUO, significantly increasing E-cadherin expression and decreasing α-smooth muscle actin (α-SMA) and the main component of the ECM [type III collagen (Col III) and fibronectin (FN)] in vivo. The results show that ISO demonstrates potent inhibition of EMT in renal tubular epithelial cells, both in vivo and in vitro. The specific interaction between ISO and Fn14 was confirmed by SPR analysis. Overexpression of Fn14 counteracts the renoprotective effects of ISO, mitigating its influence on the inactivation of the TWEAK/Fn14 signaling pathway.Conclusions: These confirmed that ISO inhibits the EMT of renal tubular epithelial cells by suppressing the TWEAK/Fn14 signaling pathway.
- 4 September 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1649327
Open AccessIsorhamnetin attenuates renal interstitial fibrosis by targeting TWEAK/Fn14-mediated epithelial–mesenchymal transition
Introduction: Isorhamnetin (ISO), a prominent active compound found in the fruits of Hippophae rhamnoides L., exhibits various pharmacological activities. Recent studies have demonstrated that ISO possesses a significant renoprotective effect. Nevertheless, the specific targets and mechanisms through which ISO exerts its effects against renal interstitial fibrosis (RIF) remain insufficiently explored. The aims of this study were to explore the protective effects of ISO regulating epithelial–mesenchymal transition (EMT) and relieving RIF and to elucidate the underlying molecular mechanisms involved in the tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor-inducible molecule 14 (Fn14) pathway.Methods: We explored the potential effects and mechanisms of ISO on RIF by using an in vitro EMT model of a transforming growth factor-β (TGF-β)-induced human proximal tubular cell line (HK-2) and an in vivo unilateral ureteral obstruction (UUO) model. The potential mechanism of the TWEAK/Fn14 pathway involving the protective action of ISO on renal tubules was explored by surface plasmon resonance (SPR) analysis and Fn14 overexpression on UUO rats.Results: Our findings reveal that ISO can enhance cell morphology and effectively inhibit the migration ability of TGF-β-induced HK-2 cells. ISO also improved renal dysfunction and reduced tubular damage induced by UUO, significantly increasing E-cadherin expression and decreasing α-smooth muscle actin (α-SMA) and the main component of the ECM [type III collagen (Col III) and fibronectin (FN)] in vivo. The results show that ISO demonstrates potent inhibition of EMT in renal tubular epithelial cells, both in vivo and in vitro. The specific interaction between ISO and Fn14 was confirmed by SPR analysis. Overexpression of Fn14 counteracts the renoprotective effects of ISO, mitigating its influence on the inactivation of the TWEAK/Fn14 signaling pathway.Conclusions: These confirmed that ISO inhibits the EMT of renal tubular epithelial cells by suppressing the TWEAK/Fn14 signaling pathway.
- 24 March 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 346, 119688
Inhibition of oxidative stress contributes to the protective effect of Herba Siegesbeckiae on ischemic stroke by PI3K/STAT3/FOXO3a signal axis
- 24 March 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 346, 119688
Inhibition of oxidative stress contributes to the protective effect of Herba Siegesbeckiae on ischemic stroke by PI3K/STAT3/FOXO3a signal axis
- Open Access
- 9 January 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1527986
Gualou Guizhi Granule inhibits microglia-mediated neuroinflammation to protect against neuronal apoptosis in vitro and in vivo
Object: Neuroinflammation mediated by microglia has emerged as a critical factor in ischemic stroke and neuronal damage. Gualou Guizhi Granule (GLGZG) has been shown to suppress inflammation in lipopolysaccharide (LPS)-activated microglia, though the underlying mechanisms and its protective effects against neuronal apoptosis remain unclear. This study aims to investigate how GLGZG regulates the Notch signaling pathway in microglia to reduce neuroinflammation and protect neurons from apoptosis.Method: Using in vitro and in vivo models, we explored GLGZG's impact on microglia activation, pro-inflammatory cytokines, and neuronal apoptosis. Microglial cells were activated with LPS, and primary neuronal cells were exposed to LPS-activated microglia to simulate neuroinflammation. Additionally, we investigated the effects of GLGZG in combination with N-[N-[3,5-difluorophenacetyl]-L-alanyl]-S-phenylglycine t-butyl ester (DAPT) or siRNA-Notch1 to further elucidate the involvement of the Notch signaling pathway.Results: GLGZG significantly inhibited microglia activation and reduced neuroinflammation by de-creasing the levels of pro-inflammatory cytokines IL-1β, IL-6, and TNF-α in both in vitro and in vivo models. GLGZG also effectively protected against microglia-induced neuronal apoptosis. Mechanistically, GLGZG down-regulated key components of the Notch signaling pathway, in-cluding Notch-1, NICD, RBPSUH, and Hes-1, in activated microglia. Combined treatment with GLGZG and DAPT or siRNA-Notch1 demonstrated enhanced inhibition of microglial activation and neuroinflammation.Conclusion: Our findings reveal that GLGZG exerts its protective effects through the suppression of the Notch signaling pathway, thereby inhibiting microglia activation, reducing neuroinflammation, and safeguarding neurons from neuroinflammation-induced damage, offering potential as a therapeutic agent for ischemic stroke-induced neuroinflammation.
- 9 January 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1527986
Open AccessGualou Guizhi Granule inhibits microglia-mediated neuroinflammation to protect against neuronal apoptosis in vitro and in vivo
Object: Neuroinflammation mediated by microglia has emerged as a critical factor in ischemic stroke and neuronal damage. Gualou Guizhi Granule (GLGZG) has been shown to suppress inflammation in lipopolysaccharide (LPS)-activated microglia, though the underlying mechanisms and its protective effects against neuronal apoptosis remain unclear. This study aims to investigate how GLGZG regulates the Notch signaling pathway in microglia to reduce neuroinflammation and protect neurons from apoptosis.Method: Using in vitro and in vivo models, we explored GLGZG's impact on microglia activation, pro-inflammatory cytokines, and neuronal apoptosis. Microglial cells were activated with LPS, and primary neuronal cells were exposed to LPS-activated microglia to simulate neuroinflammation. Additionally, we investigated the effects of GLGZG in combination with N-[N-[3,5-difluorophenacetyl]-L-alanyl]-S-phenylglycine t-butyl ester (DAPT) or siRNA-Notch1 to further elucidate the involvement of the Notch signaling pathway.Results: GLGZG significantly inhibited microglia activation and reduced neuroinflammation by de-creasing the levels of pro-inflammatory cytokines IL-1β, IL-6, and TNF-α in both in vitro and in vivo models. GLGZG also effectively protected against microglia-induced neuronal apoptosis. Mechanistically, GLGZG down-regulated key components of the Notch signaling pathway, in-cluding Notch-1, NICD, RBPSUH, and Hes-1, in activated microglia. Combined treatment with GLGZG and DAPT or siRNA-Notch1 demonstrated enhanced inhibition of microglial activation and neuroinflammation.Conclusion: Our findings reveal that GLGZG exerts its protective effects through the suppression of the Notch signaling pathway, thereby inhibiting microglia activation, reducing neuroinflammation, and safeguarding neurons from neuroinflammation-induced damage, offering potential as a therapeutic agent for ischemic stroke-induced neuroinflammation.
- Open Access
- 9 May 2023
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 61 (1) , 779-789
Gualou Guizhi decoction promotes therapeutic angiogenesis via the miR210/HIF/VEGF pathway in vivo and in vitro
Gualou Guizhi decoction (GLGZD) is an ancient Chinese classical prescription widely used to treat ischemic stroke. However, the molecular mechanisms of GLGZD promoting angiogenesis are unavailable....
- 9 May 2023
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 61 (1) , 779-789
Open AccessGualou Guizhi decoction promotes therapeutic angiogenesis via the miR210/HIF/VEGF pathway in vivo and in vitro
Gualou Guizhi decoction (GLGZD) is an ancient Chinese classical prescription widely used to treat ischemic stroke. However, the molecular mechanisms of GLGZD promoting angiogenesis are unavailable....
- Open Access
- 31 October 2022
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 27 (10) , 296
The Role of the GRP78/PERK/ATF4 Pathway in the Ability of Gua Lou Gui Zhi Decoction to Attenuate Apoptosis by Inhibiting Endoplasmic Reticulum Stress after Ischemia-Reperfusion Injury
Background: Endoplasmic reticulum stress (ERS) is a key part of the apoptotic cascade that is initiated after cerebral ischemia-reperfusion injury and is very important for research on poststroke rehabilitation. In addition, the unfolded protein response (UPR) plays an important role in ERS because it activates downstream apoptotic signal transduction and induces apoptosis through the glucose-regulated protein 78 (GRP78)/protein kinase R (PKR)-like ER kinase (PERK)/activating transcription factor 4 (ATF4) pathway. The Gua Lou Gui Zhi Decoction (GLGZD) ameliorated neuronal apoptosis of ischemia-reperfusion injury caused by middle cerebral artery occlusion (MCAO) had been proved in our previous study. The present study aims to underly the regulatory ability of GLGZD in ERS-induced apoptosis mediated by the GRP78/PERK/ATF4 pathway. Methods: GLGZD was analyzed by HPLC. The effects of GLGZD were obversed on MCAO-induced ischemic rats. The cerebral infarct volume was detected by 2,3,5-Triphenyl-2H-Tetrazolium Chloride (TTC) Staining. Terminal Deoxynucleotidyl Transferase-Mediated dUTP-Biotin Nick End Labeling (TUNEL) were used to detect apoptosis. Transmission Electron Microscopy (TEM), Ca2+ levels and reactive oxygen species (ROS) detection were used to determine the function of endoplasmic reticulum. The GRP78/PERK/ATF4 signaling pathway was assessed by western blotting and immunohistochemistry. Results: Our results showed that GLGZD exerted its effects on ischemia-reperfusion injury by significantly promoting the restoration of the quantity and morphology of the rough ER and reducing the neuronal apoptosis rate in the ischemic cortex. Moreover, both of the intracellular ROS and Ca2+ levels in ischemic cortical cells were found significantly reduced by GLGZD. The GLGZD-treated group showed increased levels of phosphorylation in both of PERK and eukaryotic translation initiation factor 2α (eIF2α), activation of cysteinyl aspartate-specific proteinase-3 (Caspase-3), upregulation of the total protein levels of sarcoplasmic/endoplasmic Ca2+ ATPase 2α (SERCA 2α) and B-cell leukemia/lymphoma gene 2 (Bcl-2). Conclusions: These findings suggest that GLGZD reduces oxidative stress-induced injury and promotes a dynamic calcium balance, thereby inhibiting ERS and exerting an antiapoptotic effect on neuronal ischemic injury, which are closely related to the activation of GRP78/PERK/ATF4 signaling pathway.
- 31 October 2022
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 27 (10) , 296
Open AccessThe Role of the GRP78/PERK/ATF4 Pathway in the Ability of Gua Lou Gui Zhi Decoction to Attenuate Apoptosis by Inhibiting Endoplasmic Reticulum Stress after Ischemia-Reperfusion Injury
Background: Endoplasmic reticulum stress (ERS) is a key part of the apoptotic cascade that is initiated after cerebral ischemia-reperfusion injury and is very important for research on poststroke rehabilitation. In addition, the unfolded protein response (UPR) plays an important role in ERS because it activates downstream apoptotic signal transduction and induces apoptosis through the glucose-regulated protein 78 (GRP78)/protein kinase R (PKR)-like ER kinase (PERK)/activating transcription factor 4 (ATF4) pathway. The Gua Lou Gui Zhi Decoction (GLGZD) ameliorated neuronal apoptosis of ischemia-reperfusion injury caused by middle cerebral artery occlusion (MCAO) had been proved in our previous study. The present study aims to underly the regulatory ability of GLGZD in ERS-induced apoptosis mediated by the GRP78/PERK/ATF4 pathway. Methods: GLGZD was analyzed by HPLC. The effects of GLGZD were obversed on MCAO-induced ischemic rats. The cerebral infarct volume was detected by 2,3,5-Triphenyl-2H-Tetrazolium Chloride (TTC) Staining. Terminal Deoxynucleotidyl Transferase-Mediated dUTP-Biotin Nick End Labeling (TUNEL) were used to detect apoptosis. Transmission Electron Microscopy (TEM), Ca2+ levels and reactive oxygen species (ROS) detection were used to determine the function of endoplasmic reticulum. The GRP78/PERK/ATF4 signaling pathway was assessed by western blotting and immunohistochemistry. Results: Our results showed that GLGZD exerted its effects on ischemia-reperfusion injury by significantly promoting the restoration of the quantity and morphology of the rough ER and reducing the neuronal apoptosis rate in the ischemic cortex. Moreover, both of the intracellular ROS and Ca2+ levels in ischemic cortical cells were found significantly reduced by GLGZD. The GLGZD-treated group showed increased levels of phosphorylation in both of PERK and eukaryotic translation initiation factor 2α (eIF2α), activation of cysteinyl aspartate-specific proteinase-3 (Caspase-3), upregulation of the total protein levels of sarcoplasmic/endoplasmic Ca2+ ATPase 2α (SERCA 2α) and B-cell leukemia/lymphoma gene 2 (Bcl-2). Conclusions: These findings suggest that GLGZD reduces oxidative stress-induced injury and promotes a dynamic calcium balance, thereby inhibiting ERS and exerting an antiapoptotic effect on neuronal ischemic injury, which are closely related to the activation of GRP78/PERK/ATF4 signaling pathway.